Okay, let's tackle this question about the drug of choice for peptic ulcers caused by NSAID use. First, I need to recall the core concept here. The question is about peptic ulcers related to NSAID use. So, the main point is understanding the pathophysiology of NSAID-induced ulcers and the appropriate treatment.

I remember that NSAIDs inhibit cyclooxygenase (COX) enzymes, which are involved in prostaglandin synthesis. Prostaglandins protect the gastric mucosa by promoting mucus and bicarbonate secretion and maintaining blood flow. When NSAIDs block COX, especially COX-1, this protective effect is lost, leading to ulcers. So the treatment should aim to protect the stomach lining or reduce acid secretion.

The drug of choice for treating peptic ulcers, especially in NSAID users, is usually a proton pump inhibitor (PPI). PPIs like omeprazole work by irreversibly inhibiting the H+/K+ ATPase enzyme in parietal cells, reducing gastric acid secretion. This allows the ulcer to heal and reduces further irritation.

Looking at the options, the correct answer is likely a PPI. Let's consider the options. If the choices included PPIs (like omeprazole, lansoprazole), then that's the right answer. Other options might be H2 blockers (like ranitidine), antacids, or even misoprostol.

H2 blockers are less effective than PPIs in healing ulcers and reducing acid. Antacids provide temporary relief but don't promote healing. Misoprostol is a prostaglandin analog that protects the gastric mucosa but is less commonly used due to side effects like diarrhea and uterine contractions. So, the best choice is a PPI.

Now, the incorrect options: If option A was an H2 blocker, that's less effective. Option B could be an antacid, which is just for symptom relief. Option C might be misoprostol, which is an alternative but not first-line. Option D might be a COX-2 inhibitor, which is actually used to reduce NSAID-induced ulcers by preserving COX-1, but the question is about treatment, not prevention.

Clinical pearl: Remember that for NSAID-induced ulcers, PPIs are first-line. Also, COX-2 selective NSAIDs are used to prevent ulcers but not for treatment. The key is to suppress acid production to allow healing.

**Core Concept:** The pathophysiology of NSAID-induced peptic ulcers involves cyclooxygenase (COX)-1 inhibition, leading to reduced gastric mucosal protection. Treatment focuses on acid suppression and mucosal healing.

**Why the Correct Answer is Right:** Proton pump inhibitors (PPIs) are the drug of choice because they irreversibly inhibit the H+/K+ ATPase enzyme in gastric parietal cells, drastically reducing acid secretion. This promotes ulcer healing and protects the mucosa from further NSAID-induced damage. PPIs are more effective than H2-receptor antagonists in this context due to their superior acid suppression.

**Why Each Wrong Option is Incorrect:**
**Option A:** H2-receptor antagonists (e.g., ranitidine) reduce acid secretion but are less effective than PPIs in healing NSAID-induced ulcers

✓ Correct Answer: D. Esomeprazole